| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/27/2006 | US20060166877 Methods of protecting against radiation damage using alpha thymosin |
| 07/27/2006 | US20060166876 Delocalization molecules and use thereof |
| 07/27/2006 | US20060166875 Single chain recombinant t cell receptors |
| 07/27/2006 | US20060166874 Fvii or fviia variants having increased clotting activity |
| 07/27/2006 | US20060166869 Novel use of lipopeptide preparations |
| 07/27/2006 | US20060166868 Vegf peptides and their use |
| 07/27/2006 | US20060166864 Methods for modulating telomerase activity |
| 07/27/2006 | US20060166863 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/27/2006 | US20060166861 Inclusion compound of porphyrin metal complex and albumin |
| 07/27/2006 | US20060166860 Zinc transporter compositions for the treatment of cardiovascular diseases |
| 07/27/2006 | US20060166329 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 07/27/2006 | US20060166328 IGF-I fusion polypeptides and therapeutic uses thereof |
| 07/27/2006 | US20060166327 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166320 In vitro expression of the HCV ARFP/F-core‘coding open reading frame |
| 07/27/2006 | US20060166318 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 07/27/2006 | US20060166314 Method for rational mutagenesis of alpha/beta t-cell receptors and correspondingly mutated mdm2-protein specific alpha/beta t-cell ceceptores |
| 07/27/2006 | US20060166312 Novel microorgnaism sensitive to lysozyme |
| 07/27/2006 | US20060166311 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 07/27/2006 | US20060166310 Serotonin receptor |
| 07/27/2006 | US20060166309 Novel G-protein coupled receptors |
| 07/27/2006 | US20060166290 Primary central nervous system tumor specific BEHAB isoforms |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166267 Facilitates the isolation of proteins from the cell nucleus interior as an independent fraction by separating the complete proteome into partial proteomes and thus makes this fraction available for further analyses for the first time in adequate purity and quality |
| 07/27/2006 | US20060166265 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 07/27/2006 | US20060166260 Visualization of avian eggs |
| 07/27/2006 | US20060166259 APM1 biallelic markers and uses thereof |
| 07/27/2006 | US20060166256 IL-1 receptor accessory protein |
| 07/27/2006 | US20060166252 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166220 having apoptotic activity; exhibited anti-proliferative activity when expressed in transformed cells |
| 07/27/2006 | US20060166214 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 07/27/2006 | US20060166213 Novel compositions and methods in cancer |
| 07/27/2006 | US20060166209 Growth hormone variations in humans and its uses |
| 07/27/2006 | US20060166207 Hsan II related gene and expression products and uses thereof |
| 07/27/2006 | US20060166198 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 07/27/2006 | US20060166194 Diagnosis and treatment of cancer |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166187 Hbv precore protein capable of forming particles |
| 07/27/2006 | US20060166186 Detecting a compartment or a macromolecule of a cell by expressing a polynucleotide encoding chimeric polypeptide in the cell having single chain Fv region that binds a detectable molecule and a S-AKAP84 region that binds the macromolecule or targets the compartment; exposing cell to molecule; analyzing |
| 07/27/2006 | US20060165730 Polysaccharide and glycoconjugate vaccines |
| 07/27/2006 | US20060165729 Protein from photobacterium damselae and use thereof |
| 07/27/2006 | US20060165728 Campylobacter glycans and glycopeptides |
| 07/27/2006 | US20060165727 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes |
| 07/27/2006 | US20060165726 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like |
| 07/27/2006 | US20060165725 HBV drug resistance drug resistance detection methods |
| 07/27/2006 | US20060165723 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 07/27/2006 | US20060165719 Plasmodium falciparum antigens and methods of use |
| 07/27/2006 | US20060165718 Immunizing compositions and methods of use |
| 07/27/2006 | US20060165715 Gp41 inhibitor |
| 07/27/2006 | US20060165714 Peptides for vaccination against human CMV |
| 07/27/2006 | US20060165713 Vaccine |
| 07/27/2006 | US20060165712 can catalyze site-selective acyl transfer |
| 07/27/2006 | US20060165709 stimulate T cytotoxic lymphocytes in a mammal |
| 07/27/2006 | US20060165708 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 07/27/2006 | US20060165707 Substances |
| 07/27/2006 | US20060165703 Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis |
| 07/27/2006 | US20060165698 Polypeptide from ink of molluscs; L-lysine or L-arginine oxidase capable of producing hydrogen peroxide in tumor tissues with less toxic side effects upon normal cells |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | US20060165679 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2) |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165677 recombinant dimer consisting of two IgE-dependent histamine releasing factor (HRF), known as translationally controlled tumor protein(TCTP); for treatment of allergic diseases including asthma and rhinitis or malaria |
| 07/27/2006 | US20060165664 Method of inducing an enhanced immune response against hiv |
| 07/27/2006 | US20060165654 Peptides and recombinant proteins mimicking interferons |
| 07/27/2006 | US20060165651 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/27/2006 | US20060165650 Rantes-derived peptides with anti-hiv activity |
| 07/27/2006 | US20060165634 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof |
| 07/27/2006 | US20060165618 Photoactivatable composition and uses thereof |
| 07/27/2006 | DE19858777B4 Verfahren zur teilweisen oder vollständigen Trennung von glykosilierten und nicht-glykosilierten Proteinen A process for the partial or complete separation of glycosylated and non-glycosylated proteins, |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | DE102004058306A1 Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden A process for the production of carboxy-terminal amidated peptides |
| 07/27/2006 | CA2595902A1 Binding compounds, immunogenic compounds and peptidomimetics of the beta-3 hairpin loop of cystine-knot growth factors |
| 07/27/2006 | CA2595800A1 Specific binding members for ngf |
| 07/27/2006 | CA2595462A1 Hla fusion molecules and uses thereof |
| 07/27/2006 | CA2595461A1 Method for producing albumin conjugates containing gyrase inhibitors |
| 07/27/2006 | CA2595163A1 Yersinia spp. polypeptides and methods of use |
| 07/27/2006 | CA2595063A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | CA2594890A1 Estrogen receptor structure |
| 07/27/2006 | CA2594629A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | CA2594612A1 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| 07/27/2006 | CA2594423A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | CA2593520A1 Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 07/27/2006 | CA2563823A1 Beta-peptides |
| 07/26/2006 | EP1683871A2 Nucleic acid ligands and methods for producing the same |
| 07/26/2006 | EP1683867A1 Groups of Borrelia burgdorferi and Borrelia afzelii that cause lyme disease in humans |
| 07/26/2006 | EP1683866A2 Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof |
| 07/26/2006 | EP1683865A2 Mammalian proteins and in particular CD200 |
| 07/26/2006 | EP1683864A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/26/2006 | EP1683861A1 In vitro method for obtaining recombined polynucleotide sequences, sequence libraries and resulting sequences |
| 07/26/2006 | EP1683859A2 Putative gene coding for Catechol 1,2-Dioxygenase from Corynebacterium glutamicum |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1683809A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/26/2006 | EP1683808A1 Means and methods for breaking noncovalent binding interactions between molecules |
| 07/26/2006 | EP1683807A1 Combination products for use in antitumoral treatment, comprising an antibody capable of inhibiting the activity of CSF-1 |
| 07/26/2006 | EP1683529A1 Inclusion compound of porphyrin metal complex and albumin |
| 07/26/2006 | EP1683056A2 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
| 07/26/2006 | EP1682866A2 Gel-shell beads with adsorbed or bound biomolecules |
| 07/26/2006 | EP1682668A2 Plant transcriptional regulators |